Skip to content

Charles R. Schuster

6 papers in the library · 367 citations · publishing 1980-1988

Papers

Sort Most recent Most cited

Discriminative stimulus and subjective effects of smoked marijuana in humans.

Psychopharmacology 1988 L D Chait, S M Evans, K A Grant et al.

The discriminative stimulus (DS) effects of smoked marijuana were studied by training marijuana smokers to discriminate between the effects of marijuana containing 2.7% delta 9-THC (M) and marijuana containing 0.0% delta 9-THC (P). In addition to measures of discrimination responding, subjective effects were assessed with standardized mood questionnaires. The post-smoking increase in expired...

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Journal of Pharmacology and Experimental Therapeutics April 1, 1987 Deborah L. Commins, Georgetta Vosmer, R. Virus et al.

(+/-)-3,4-Methylenedioxymethylamphetamine (MDMA) was administered s.c. to rats (10, 20 or 40 mg/kg b. wt.) and guinea pigs (20 mg/kg) twice a day for 4 days, 2 weeks before decapitation. Norepinephrine, dopamine and serotonin (5-HT) levels were assayed in the hippocampus, hypothalamus, striatum and neocortex. In rats, MDMA produced dose-dependent reductions in 5-HT in all brain regions...

The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.

Drug and Alcohol Dependence October 1, 1986 J B Kamien, C E Johanson, Charles R. Schuster et al.

Recently, attention has been focused on (+/-)-methylenedioxymethamphetamine (MDMA), a psychotomimetic agent chemically closely related to the psychomotor stimulant methamphetamine, and also to the hallucinogen mescaline. In the present experiment, the effects of MDMA and (+/-)-3,4-methylenedioxyamphetamine (MDA) were determined in rhesus monkeys that were trained to discriminate intravenously...

DOI: 10.1016/0376-8716(86)90046-3 (opens in new tab) Animals Macaca mulatta Amphetamines N-methyl-3,4-methylenedioxyamphetamine +6

Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals

Science September 6, 1985 George A. Ricaurte, Guy K. Bryan, L. Strauss et al. 367 citations

(±)-3,4-Methylenedioxyamphetamine (MDA), an amphetamine analog with hallucinogenic activity, produced selective long-lasting reductions in the level of serotonin, the number of serotonin uptake sites, and the concentration of 5-hydroxyindoleacetic acid in rat brain. Morphological studies suggested that these neurochemical deficits were due to serotonin nerve terminal degeneration. These results...

DOI: 10.1126/science.4023719 (opens in new tab) Serotonin Amphetamine Hallucinogen Pharmacology

Single-dose study of nabilone in anxious volunteers.

The Journal of Clinical Pharmacology 1981 R M Glass, E H Uhlenhuth, F W Hartel et al.

The effects of single oral doses of nabilone, a synthetic cannabinoid, were studied in eight anxious volunteer subjects. Each subject had two exposures to placebo and three dose levels of nabilone at one-week intervals in a single-blind balanced Latin-square design after the nabilone dose range was determined by each subject's response to a test dose. Heart rate and blood pressure were...

A single dose study of nabilone, a synthetic cannabinoid.

Psychopharmacology 1980 R M Glass, E H Uhlenhuth, F W Hartel et al.

The effects of single oral doses of nabilone, a synthetic cannabinoid, were studied in four anxious volunteer subjects. Each subject had two exposures to placebo and three dose levels of nabilone at 1 week intervals in a single blind balanced Latin square design after the nabilone dose range was determined by each subject's response to a test dose. The Profile of Mood States (POMS), a...